Americans more likely to seek surgical care during pandemic if hospital staff is vaccinated

A new study found Americans are more likely to have surgery during a pandemic such as COVID-19 if they are vaccinated, the hospital staff are vaccinated, the surgery is urgent and the surgery is an outpatient procedure. The study was published in the journal Vaccine.[1]

The study sheds additional light on what patients want regarding the recent debate about whether healthcare organizations should require clinicians to be vaccinated. Some healthcare systems do not require vaccines for COVID or the annual flu, while others have strict vaccination policies even prior to COVID. The study also reinforced the fact that patients want outpatient procedures to avoid overnight stays.

“It’s critical to understand what factors affect a patient’s decision to have surgery during an infectious pandemic if we want to help reduce deaths and illness. These factors include vaccination status of the patient and hospital staff, the need and length of hospital stay, and urgency of the procedure,” said Keith Ruskin, MD, FASA, study co-author, member of the American Society of Anesthesiologists (ASA) Committee on Patient Safety and Education and professor of anesthesia and critical care at the University of Chicago, in a statement. “Having this knowledge could help guide health care institutions’ future vaccine resource allocations and policies for vaccine requirements.”

The biggest impact on a patients’ willingness to have surgery during a pandemic was the urgency of surgery. Participants viewed life-saving surgery as more essential than an elective procedure like knee replacements during a pandemic. 

The study also showed participants who were vaccinated were more willing to have a surgical procedure than their unvaccinated counterparts. Requiring hospital staff to be vaccinated also played a key role, with 24% of respondents saying they were unwilling to have lifesaving surgery without universal vaccination of hospital staff. This number decreased to 15% with universal vaccination, the authors note.

 

“Making the choice to not have surgery for an actual health problem could increase the risk of potential illness and disease attributable to pandemic-related fears,” explained Anna Clebone Ruskin, MD, study co-author and associate professor of anesthesia and critical care, University of Chicago, said in the statement. “This suggests a potential opportunity for public education.”

In the study conducted by the University of Chicago and Embry-Riddle Aeronautical University, 2,006 U.S. adults aged 18 or older were surveyed about a hypothetical surgery. They were recruited electronically using Amazon’s Mechanical Turk and answered a 26-item survey. Willingness to undergo surgery was assessed under several circumstances, including the urgency of surgery, time in the hospital, vaccination status of the participant, and if the hospital required all staff to be vaccinated. Data were collected in June 2021 amid the current SARS-CoV-2 pandemic.

Find more content on the impact of COVID-19 on healthcare


Reference:

1. Anna Clebone Ruskina, Stephen Rice, Michael O'Connor, et al. Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study. Vaccine. Volume 40, Issue 26, 9 June 2022, Pages 3536-3539. https://doi.org/10.1016/j.vaccine.2022.05.013.

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.